glycidyl nitrate has been researched along with Community Acquired Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angus, DC; Ding, J; Ferrell, RE; Garcia, M; Harris, TB; Kellum, JA; Kritchevsky, SB; Li, R; Newman, AB; Wunderink, RG; Yaffe, K; Yende, S; Zmuda, J | 1 |
| Blasi, F; Braga, P; Cazzola, M; Cosentini, R; Tarsia, P | 1 |
1 review(s) available for glycidyl nitrate and Community Acquired Infection
| Article | Year |
|---|---|
Therapies in development for community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Community-Acquired Infections; Drug Design; Drug Resistance, Multiple, Bacterial; Humans; Nucleic Acid Synthesis Inhibitors; Peptidoglycan; Pneumonia, Bacterial; Protein Synthesis Inhibitors | 2002 |
1 other study(ies) available for glycidyl nitrate and Community Acquired Infection
| Article | Year |
|---|---|
4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.
Topics: Aged; Blood; Cohort Studies; Community-Acquired Infections; Cytokines; Female; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Lipopolysaccharides; Longitudinal Studies; Male; Osmolar Concentration; Peptidoglycan; Phenotype; Plasminogen Activator Inhibitor 1; Pneumonia; Polymorphism, Genetic; Polymorphism, Single Nucleotide; White People | 2007 |